ID: ALA14231

Max Phase: Preclinical

Molecular Formula: C11H11N3O2

Molecular Weight: 217.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc([N+](=O)[O-])ccc1Cn1ccnc1

Standard InChI:  InChI=1S/C11H11N3O2/c1-9-6-11(14(15)16)3-2-10(9)7-13-5-4-12-8-13/h2-6,8H,7H2,1H3

Standard InChI Key:  SDWXRYIAMVYSNC-UHFFFAOYSA-N

Associated Targets(non-human)

Ephx1 Epoxide hydrolase 1 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 217.23Molecular Weight (Monoisotopic): 217.0851AlogP: 2.15#Rotatable Bonds: 3
Polar Surface Area: 60.96Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.46CX LogP: 2.26CX LogD: 2.22
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.58Np Likeness Score: -2.17

References

1. James MO, Sloan KB..  (1985)  Structural features of imidazole derivatives that enhance styrene oxide hydrolase activity in rat hepatic microsomes.,  28  (8): [PMID:4020834] [10.1021/jm00146a028]

Source